Dr Lal PathLabs posts higher Q1 profit as revenue rises 19%

Demand for preventive health packages and routine testing lifted quarterly earnings, while the board cleared stakes in Sunshine Healthcare and Neuome Technologies and approved a 5-rupee interim dividend.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.